可改变的乳房切除术后放疗因素及其对植入物乳房再造结局的影响
该回顾性病历回顾纳入68例(70侧乳房)乳房切除后即刻放置组织扩张器并接受乳房切除术后放疗的患者,分析放疗技术、bolus方案、X线能量、分割方式、最大热点及接受超过105%或107%处方剂量组织体积等可改变放疗因素与再造并发症的关系。总体并发症率28.6%,感染最常见(24.3%),超过半数感染需取出组织扩张器或植入物(15.7%)。需取出植入物者最大放疗热点更高且接近统计学显著(114.5%±7.2% vs 111.4%±4.4%,P=0.059)。
要点
- 总体并发症率28.6%,感染最常见(24.3%),其中15.7%需取出扩张器或植入物。
- 需取出植入物者最大热点更高且接近统计学显著(114.5%±7.2% vs 111.4%±4.4%,P=0.059)。
- 放疗技术及其他放疗特征间并发症率无显著差异。
核心结论
- 尽量减少放疗热点及接受超过处方剂量照射的组织体积,可能改善植入物乳房再造后接受乳房切除术后放疗患者的再造结局。
研究设计与样本
- 回顾性病历回顾,纳入68例(70侧乳房)接受乳房切除并即刻放置组织扩张器后行乳房切除术后放疗的患者。
- 收集放疗技术、bolus方案、X线能量、分割方式、最大放疗热点及接受超过105%或107%处方剂量组织体积等放疗特征。
- 分析放疗开始后发生的再造并发症与上述放疗特征的关系。
- 证据等级:治疗性,III级。
主要发现
- 总体并发症率28.6%,感染为最常见并发症(24.3%),超过半数感染需取出组织扩张器或植入物(15.7%)。
- 需取出植入物者最大放疗热点高于未取出者,接近统计学显著(114.5%±7.2% vs 111.4%±4.4%,P=0.059)。
- 需取出植入物者接受超过105%处方剂量组织体积大于未取出者(42.1%±17.1% vs 33.0%±20.9%,P=0.176),未达统计学显著。
- 需取出植入物者接受超过107%处方剂量组织体积大于未取出者(16.4%±14.5% vs 11.3%±14.6%,P=0.313),未达统计学显著。
- 不同放疗技术及其他所研究的放疗特征间并发症率无显著差异。
关键数值与推荐
- 总体并发症率28.6%(68例、70侧乳房)。
- 感染发生率24.3%,其中需取出组织扩张器或植入物者占15.7%。
- 需取出植入物者最大放疗热点114.5%±7.2% vs 未取出者111.4%±4.4%(P=0.059)。
- 需取出植入物者接受超过105%处方剂量组织体积42.1%±17.1% vs 未取出者33.0%±20.9%(P=0.176)。
- 需取出植入物者接受超过107%处方剂量组织体积16.4%±14.5% vs 未取出者11.3%±14.6%(P=0.313)。
临床怎么用
- 原文结论认为尽量减少放疗热点及接受超过处方剂量照射的组织体积,可能改善植入物乳房再造后接受乳房切除术后放疗患者的再造结局。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Intensity-modulated radiation therapy and other modifiable radiation factors have been associated with decreased radiation toxicity. These factors could allow for improved reconstructive outcomes in patients requiring postmastectomy radiation therapy (PMRT). However, they have not yet been well studied in implant-based breast reconstruction. METHODS: The authors performed a retrospective chart review of patients who underwent mastectomy with immediate tissue expander placement followed by PMRT. Radiation characteristics were collected, including radiation technique, bolus regimen, x-ray energy, fractionation, maximum radiation hot spot, and tissue volume receiving more than 105% or more than 107% of the prescription dose. Reconstructive complications occurring after initiation of PMRT were analyzed with respect to these radiation characteristics. RESULTS: Sixty-eight patients (70 breasts) were included in this study. The overall complication rate was 28.6%, with infection being the most common complication (24.3%), requiring removal of the tissue expander or implant in greater than half of infections (15.7%). Maximum radiation hot spot was greater in patients who required explantation after PMRT, and this approached statistical significance (114.5% ± 7.2% versus 111.4% ± 4.4%; P = 0.059). Tissue volume receiving more than 105% and 107% were also greater in patients who required explantation after PMRT (42.1% ± 17.1% versus 33.0% ± 20.9% and 16.4% ± 14.5% versus 11.3% ± 14.6%, respectively); however, this was not statistically significant ( P = 0.176 and P = 0.313, respectively). There were no significant differences in complication rates between patients with respect to radiation technique or other radiation characteristics studied. CONCLUSION: Minimizing the radiation hot spots and volumes of tissue receiving greater than the prescription dose of radiation may improve reconstructive outcomes in patients undergoing implant-based breast reconstruction followed by PMRT. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Barnes LL, Chew J, Lem M, et al. Modifiable Postmastectomy Radiation Therapy Factors and Impact on Implant-Based Breast Reconstruction Outcomes. Plast Reconstr Surg. 2023. PMID: 37335545. doi:10.1097/PRS.0000000000010824
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。